CKAP4 | Cytoskeleton-associated protein 4 | Cytoskeleton related proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CLCA2 | Chloride channel accessory 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
CLCC1 | Chloride channel CLIC-like 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
CLCN7 | Chloride channel, voltage-sensitive 7 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
CLDN10 | Claudin 10 | Predicted membrane proteins
| | | | | Tissue enhanced |
CLDN16 | Claudin 16 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CLDN7 | Claudin 7 | Cancer-related genes Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Mixed |
CLEC12A | C-type lectin domain family 12, member A | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC2L | C-type lectin domain family 2, member L | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
CLEC4G | C-type lectin domain family 4, member G | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CLEC4M | C-type lectin domain family 4, member M | CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CLGN | Calmegin | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CLYBL | Citrate lyase beta like | Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CMTM5 | CKLF-like MARVEL transmembrane domain containing 5 | Predicted membrane proteins
| | | | | Tissue enriched |
CNTNAP2 | Contactin associated protein-like 2 | Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
CNTNAP4 | Contactin associated protein-like 4 | Predicted membrane proteins
| | | | | Tissue enriched |
COL17A1 | Collagen, type XVII, alpha 1 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
COMT | Catechol-O-methyltransferase | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
COX4I1 | Cytochrome c oxidase subunit IV isoform 1 | Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
COX6C | Cytochrome c oxidase subunit VIc | Cancer-related genes Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
COX8A | Cytochrome c oxidase subunit VIIIA (ubiquitous) | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
CPQ | Carboxypeptidase Q | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CPT1A | Carnitine palmitoyltransferase 1A (liver) | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CR1 | Complement component (3b/4b) receptor 1 (Knops blood group) | Blood group antigen proteins CD markers Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CR2 | Complement component (3d/Epstein Barr virus) receptor 2 | CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
CREB3L1 | CAMP responsive element binding protein 3-like 1 | Cancer-related genes Predicted intracellular proteins Predicted membrane proteins Transcription factors
| | | | | Mixed |
CREB3L4 | CAMP responsive element binding protein 3-like 4 | Predicted intracellular proteins Predicted membrane proteins Transcription factors
| | | | | Expressed in all |
CRYAB | Crystallin, alpha B | Cancer-related genes Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CS | Citrate synthase | Citric acid cycle related proteins Enzymes Mitochondrial proteins Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CSF3R | Colony stimulating factor 3 receptor (granulocyte) | Cancer-related genes CD markers Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CSPG4 | Chondroitin sulfate proteoglycan 4 | Predicted membrane proteins
| | | | | Mixed |
CSPG5 | Chondroitin sulfate proteoglycan 5 (neuroglycan C) | Predicted membrane proteins
| | | | | Tissue enriched |
CTCFL | CCCTC-binding factor (zinc finger protein)-like | Predicted intracellular proteins Predicted membrane proteins Transcription factors
| | | | | Tissue enriched |
CUZD1 | CUB and zona pellucida-like domains 1 | Predicted membrane proteins
| | | | | Mixed |
CX3CL1 | Chemokine (C-X3-C motif) ligand 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CXADR | Coxsackie virus and adenovirus receptor | Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CYB5A | Cytochrome b5 type A (microsomal) | Disease related genes Mitochondrial proteins Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CYP19A1 | Cytochrome P450, family 19, subfamily A, polypeptide 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
CYP1B1 | Cytochrome P450, family 1, subfamily B, polypeptide 1 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
CYP3A43 | Cytochrome P450, family 3, subfamily A, polypeptide 43 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
CYP4F2 | Cytochrome P450, family 4, subfamily F, polypeptide 2 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
DAG1 | Dystroglycan 1 (dystrophin-associated glycoprotein 1) | Cytoskeleton related proteins Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
DCC | DCC netrin 1 receptor | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
DCHS1 | Dachsous cadherin-related 1 | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Mixed |
DCLK1 | Doublecortin-like kinase 1 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
DCT | Dopachrome tautomerase | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
DDO | D-aspartate oxidase | Enzymes Predicted membrane proteins
| | | | | Mixed |
DDOST | Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit (non-catalytic) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
DFNB31 | Deafness, autosomal recessive 31 | Disease related genes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DHODH | Dihydroorotate dehydrogenase (quinone) | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |